ArticleBioinformatics (Oxford, England)2026
VDJ-REMIX: REpertoire Module Identification and eXploration.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
motivationHigh-throughput sequencing of B and T cell repertoires provides unprecedented insights into adaptive immunity but generates high-dimensional feature sets that are challenging to interpret. Standard dimensionality reduction techniques are often suboptimal for adaptive immune receptor repertoire (AIRR) data, which exhibits multi-collinearity, heterogeneous data types, and missingness.
resultsHere, we present VDJ-REMIX, an R package implementing a robust, network-based framework to deconstruct complex repertoire feature matrices into biologically interpretable modules. By refactoring weighted correlation network analysis (WGCNA), VDJ-REMIX provides a tailored workflow for preprocessing, imputation, and modularization of immune repertoire data. We demonstrate its utility across diverse contexts, including autoimmunity, inflammation, and acute infection. In autoimmune patients, VDJ-REMIX identified distinct B cell signatures that stratified diseases and revealed opposing dynamic responses to B cell-depleting versus anti-proliferative therapies. In COVID-19 and non-COVID-19 sepsis patients, it distinguished disease-specific signatures from shared severe infection responses and identified modules correlated with severity. Analysis of flow-sorted B cell populations stratified by FCGR2B genotype recapitulated known tolerance defects and uncovered population-specific repertoire signatures linked to inhibitory receptor dysfunction, providing orthogonal validation of module biological coherence. Finally, applied to a single-cell multi-omics dataset of immune cells in pancreatic ductal adenocarcinoma (PDAC) combining gene expression with AIRR-seq, VDJ-REMIX recovered modules linking BCR isotype usage and clonality to cytotoxic, interferon-responsive, and regulatory immune programmes. VDJ-REMIX is a versatile tool enabling systematic exploration of immunological variation and biomarker discovery from complex immune repertoire data. AVAILABILITY AND IMPLEMENTATION: VDJ-REMIX is freely available at https://github.com/Bashford-Rogers-lab/vdjremix.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.